Chung-Pin H Chen

This inventor holds 12 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 3 EPO patents. Top assignees: Bristol-Myers Squibb Compnay, Viiv Healthcare UK (No. 4) Limited. Active years: 2002-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chung-Pin H Chen. Retrieved from https://idiyas.com/inventor/chung-pin-h-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 4

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 9.1

ph-index = 5

Forward Citations = 102(Granted Patents)

Location History:

Madison, CT (US) (2002 - 2014)
Wallingford, CT (US) (2022)

Company Filing History:

11 out of 3,737

Bristol-Myers Squibb Compnay

patents

1 out of 8

Viiv Healthcare UK (No. 4) Limited

patents

Years Active: 2002-2022

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11369624 - Salts of prodrugs of piperazine and substituted piperidine antiviral agents (2022-06-28),

2. 8871771 - Salts of prodrugs of piperazine and substituted piperidine antiviral agents (2014-10-28),

3. 8461333 - Salts of prodrugs of piperazine and substituted piperidine antiviral agents (2013-06-11),

4. 8436168 - Methods of making HIV attachment inhibitor prodrug compound and intermediates (2013-05-07),

5. 8168615 - Prodrugs of piperazine and substituted piperidine antiviral agents (2012-05-01),

6. 7851476 - [object Object] (2010-12-14),

7. 7745625 - Prodrugs of piperazine and substituted piperidine antiviral agents (2010-06-29),

8. 7723338 - [object Object] (2010-05-25),

9. 7550619 - Intermediates in the preparation of the antiviral agent [1S-(1α, 3α, 4β)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxmethyl)-2-methylenecyclopentyl]-6H-purin-6-one (2009-06-23),

10. 7034152 - Process for preparing the antiviral agent [1S-(1alpha,3 alpha,4beta )]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one (2006-04-25),

11. 6448401 - Process for water soluble azole compounds (2002-09-10),

12. 6362172 - Water soluble prodrugs of azole compounds (2002-03-26),

Title: Innovations of Chung-Pin H Chen

Introduction

Chung-Pin H Chen is a notable inventor based in Madison, CT (US), recognized for his significant contributions to the field of pharmaceutical sciences. With a total of 12 patents to his name, he has made remarkable strides in developing antiviral agents.

Latest Patents

One of his latest patents includes the invention of salts of prodrugs of piperazine and substituted piperidine antiviral agents. This invention provides for prodrug Compounds I, pharmaceutical compositions thereof, and their use in treating HIV infection. Additionally, it offers intermediate Compounds II that are useful in the synthesis of prodrug Compounds I.

Career Highlights

Chung-Pin H Chen has had a distinguished career, working with prominent companies such as Bristol-Myers Squibb Company and ViiV Healthcare UK (No. 4) Limited. His work has significantly impacted the development of antiviral therapies.

Collaborations

Throughout his career, he has collaborated with esteemed colleagues, including Yasutsugu Ueda and Timothy P Connolly. These collaborations have further enhanced his innovative contributions to the pharmaceutical industry.

Conclusion

Chung-Pin H Chen's work exemplifies the spirit of innovation in the pharmaceutical field, particularly in the development of antiviral agents. His patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.